Bohula, E. A. et al. Inflammatory and cholesterol risk in the FOURIER trial. Circulation 138, 131–140 (2018).
Article CAS PubMed Google Scholar
Bugger, H. & Zirlik, A. Anti-inflammatory strategies in atherosclerosis. Hamostaseologie 41, 433–442 (2021).
Stone, G. W. et al. A prospective natural-history study of coronary atherosclerosis. N. Engl. J. Med. 364, 226–235 (2011).
Article CAS PubMed Google Scholar
Erlinge, D. et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study. Lancet 397, 985–995 (2021).
Article CAS PubMed Google Scholar
Wolf, D., Zirlik, A. & Ley, K. Beyond vascular inflammation-recent advances in understanding atherosclerosis. Cell. Mol. Life Sci. 72, 3853–3869 (2015).
Article CAS PubMed PubMed Central Google Scholar
Kim, C. et al. Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing. Cell 173, 879–893.e13 (2018).
Article CAS PubMed PubMed Central Google Scholar
Winkels, H. et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry. Circ. Res. 122, 1675–1688 (2018).
Article CAS PubMed PubMed Central Google Scholar
Wolf, D. et al. Pathogenic autoimmunity in atherosclerosis evolve from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells. Circulation 142, 1279–1293 (2020).
Article CAS PubMed PubMed Central Google Scholar
Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576–1588 (2019).
Article CAS PubMed PubMed Central Google Scholar
Leistner, D. M. et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur. Heart J. 41, 3549–3560 (2020).
留言 (0)